O prototype of retroviral Cuban, a combination of lopinavir and ritonavir, is still in the “development phase”, although the first tests produced “satisfactory preliminary results”, according to one of the leaders of the investigation carried out by the state laboratories MedSol, in statements to the Cuban news agency.

“Three pilot batches have already been prepared, the physical-chemical analysis has been carried out and the comparison will be made with the leading product”, explained the head of the company’s research and investigation group Novatec, belongs to MedSol, Adalberto Izquierdo.

The successful production of antiretroviral in Cuba it would save money and time for the island, which is under US embargo, which makes it difficult to acquire foreign goods, including medicines and medical equipment that have more than 10% of North American components.

According to Cuban experts, his version of the drug could “even be exported” in the long run.

However, in order to produce it, Cuba must first overcome several obstacles, including the absence of the “heating machine that fuses the two main active“of the antiviral.

“The country today does not have this equipment”, he assured Izquierdo.

The solution needs “adaptations in Cuban technology” that allow the prestigious island biopharmaceutical industry to produce a medicine with “the same quality specifications as the leading product”, manufactured by the American company AbbVie Inc.

Kaletra is the trade name of the antiviral composed of a combination of lopinavir and ritonavir, used with success in the treatment of HIV-AIDS. Side effects include digestive discomfort and diarrhea.

Although it has not been scientifically proven that any of the existing drugs cure or prevent the spread of covid-19, the Kaletra it is one of the most widely used in the treatment of the disease.

Cuba also includes it in its protocol against the new coronavirus, which has already accumulated 1,337 confirmed cases and 51 Deaths since the beginning of the epidemic in the country.

The Cuban antiviral Iterferon Alpha 2B was one of the drugs used in China at the beginning of pandemic, which motivated at least 15 countries in South America, Africa and Asia requesting information or providing it.

Without providing concrete figures, the state drug group BioCubaFarma ensured to have enough ‘stock’ of retroviral to cover demand inside and outside the country.

Despite Cuba’s chronic scarcity, attributed in part to the US embargo and which affects also the pharmaceutical industry, directors gives BioCubaFarma insisted that the 22 drugs considered to be able to help treat coronavirus in one way or another.

Globally, according to a report by the news agency AFP, a pandemic in covid-19 has already caused more than 200 thousand deaths and infected more than 2.8 million people in 193 countries and territories.

More than 766,000 patients were considered cured.

Always be the first to know.
Follow the site chosen for the fourth consecutive year Consumer Choice.
Download our free App.

Google Play Download


Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.